BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://futurebloodtesting.org
X-WR-CALDESC:Events for 
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240705T120000
DTEND;TZID=Europe/London:20240705T130000
DTSTAMP:20260405T175549
CREATED:20240603T134411Z
LAST-MODIFIED:20241011T115848Z
UID:1606-1720180800-1720184400@futurebloodtesting.org
SUMMARY:Photonic Biosensing of Alzheimer's Disease Biomarkers
DESCRIPTION:Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-07-05\n\nAbstract: A major issue facing the diagnosis of neurodegenerative disease is the availability of an accessible\, scalable\, and highly sensitive technology. Compelling evidence now suggests that the abundance of blood-based dementia biomarkers\, including ß-amyloid (Aß) and tau\, and their ratios\, change considerably before clinical symptoms arise. Assessing these parameters via a straightforward blood test could facilitate early-stage diagnosis\, recruitment of patients into clinical trials\, and open a platform for at-home treatment monitoring. Current technologies for biomarker analysis are resource-intensive\, rely on cerebrospinal fluid extraction\, and are not widely adopted. Here\, we demonstrate the detection of blood-based biomarkers using a next-generation\, label-free photonic biosensor based on the principle of chirped guided mode resonance (GMR) spectroscopy. Our handheld GMR device is a low-cost optical biosensor suitable for the real-time\, sensitive and parallel detection of dementia biomarkers. The technology utilizes wavelength scale grating structures to excite a standing wave that is sensitive to refractive index changes on the sensor surface. When target biomarkers bind to antibodies on the sensor surface\, a refractive index change gives rise to a detectable shift in resonance wavelength. The chirped element of the GMR translates spectral information into spatial position\, allowing biomarker binding to be detected by imaging the spatial position of the optical resonance on a simple camera detector. Our label-free technology outperforms competing modalities including surface plasmon approaches\, has demonstrable sensitivity to pg/mL concentrations of low molecular weight protein biomarkers\, offers a wide dynamic range\, is mechanically and thermally stable\, enables the real-time detection of at least eight biomarkers in parallel\, and corrects for non-specific binding. By applying our biosensing approach to the detection of dementia biomarkers\, we have demonstrated the real-time and quantitative detection of Aß in laboratory analytes\, paving the way for further developments towards a blood test technology to support disease diagnosis\, at-home treatment monitoring\, and the democratization of testing.\n\nBio: Dr Steven Quinn obtained an MPhys in Physics from the University of St. Andrews (2009) and an MSc in Radiation\, Oncology and Biology from the University of Oxford (2010). After his PhD (St Andrews\, 2013) and a postdoctoral position at the University of Glasgow (2013-2016)\, he took up a Lindemann Trust Fellowship at the Massachusetts Institute of Technology (2016-2017). In 2017\, he was appointed to a Lectureship at the University of York and was awarded an Alzheimer’s Research UK Fellowship in 2019. Steven is now a Senior Lecturer\, and his group uses a variety of analytical\, biosensing and single-molecule techniques to detect and interrogate the structure and dynamics of biomolecules implicated in dementia.\n\nThis webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
URL:https://futurebloodtesting.org/event/photonic-biosensing-of-alzheimers-disease-biomarkers/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://futurebloodtesting.org/wp-content/uploads/2024/06/FBTN-Webinar-Steve-.png
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240912T120000
DTEND;TZID=Europe/London:20240912T130000
DTSTAMP:20260405T175549
CREATED:20240819T143107Z
LAST-MODIFIED:20240819T143107Z
UID:1814-1726142400-1726146000@futurebloodtesting.org
SUMMARY:Multicorder - Enabling the Future of POC Diagnostics and Screening
DESCRIPTION:Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-09-12 \nAbstract: \nPrecision metabolomics and quantification for cost-effective rapid diagnosis of disease are the key goals in personalized medicine and point-of-care testing. At present\, patients are subjected to multiple test procedures requiring large laboratory equipment. Here\, we present a versatile single complementary metal–oxide–semiconductor chip forming a platform to address personalized needs through on-chip multimodal optical and electrochemical detection that will reduce the number of tests that patients must take. The chip integrates interleaved sensing subsystems for quadruple-mode colorimetric\, chemiluminescent\, surface plasmon resonance\, and hydrogen ion measurements. These subsystems include a photodiode array and a single photon avalanche diode array and an array of ion sensitive field-effect transistors. The sensor arrays are distributed uniformly over an active area on the chip surface in a scalable and modular design. Bio-functionalization of the physical sensors yields a highly selective simultaneous multiple-assay platform in a disposable format. We have demonstrated its versatile capabilities through various applications such as CVD\, prostate cancer diagnosis and bleeding disorders monitoring. \nBio: \nDr Chunxiao Hu is a Lecturer in Biomedical Engineering at the University of Glasgow. His research focuses on developing miniaturised portable microsystem platforms by using advanced technologies such as microfluidics\, nanofabrication\, surface functionalization for biomedical applications. Current projects include Highly integrated chemical sensors (electrical and optical) for multiple detection of biomarkers for early cancer diagnostics; CMOS based ISFET for fast antimicrobial susceptibility testing; Wearable biosensor for continuous monitoring of stroke; Microfluidic device for neurodegenerative diseases; Microfluidic device for electrophysiological analysis of drug uptake in nematodes. \nThis webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
URL:https://futurebloodtesting.org/event/multicorder-enabling-the-future-of-poc-diagnostics-and-screening/
LOCATION:Online
CATEGORIES:Online Event
ATTACH;FMTTYPE=image/png:https://futurebloodtesting.org/wp-content/uploads/2024/08/FBTN-Webinar-Chunxiao.png
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240927T120000
DTEND;TZID=Europe/London:20240927T130000
DTSTAMP:20260405T175549
CREATED:20240903T145827Z
LAST-MODIFIED:20241011T115243Z
UID:1833-1727438400-1727442000@futurebloodtesting.org
SUMMARY:Democratising Healthcare Technology: The Role and Challenges of Participatory Design in Healthcare
DESCRIPTION:Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-09-27\n\nAbstract: In this talk\, Dr Stephen Lindsay will delve into the fundamental principles of participatory design\, focusing on its role in democratizing the development of healthcare technologies. He will begin by exploring the core definition of participatory design\, emphasizing its potential to empower users by involving them directly in the creation process. He will then contrast this approach with current Patient and Public Involvement and Engagement (PPIE) practices in the UK\, highlighting how participatory design extends beyond consultation to share decision-making in design. The talk will also examine the specific challenges of applying participatory design in healthcare\, navigating ethical considerations\, ensuring inclusivity\, and managing the complexities of working with vulnerable populations. Through case studies from his own work\, he will demonstrate how participatory design can overcome these challenges\, leading to more inclusive\, effective\, and ethically sound healthcare solutions\, and offering a critical perspective on the limitations of traditional PPIE approaches.\n\nBio: Dr Stephen Lindsay is a Lecturer in Digital Healthcare and HCI at Glasgow University. His research is cantered on participatory design\, particularly with marginalized groups such as older adults\, people living with dementia\, and individuals with brain injuries. Dr Lindsay believes that involving these under-heard voices in healthcare technology design not only fosters more ethical practices but also drives innovation. His work has addressed diverse areas\, including designing digital tools for older adults\, supporting less-literate diabetes patients in rural Pakistan\, and creating technologies that genuinely reflect patients’ needs and experiences. Through this approach\, Dr Lindsay contributes to the development of digital health tools that are both ethically sound and practically effective\, grounded in the lived experiences of those they aim to serve.\n\nThis webinar is part of the 2024 Future Blood Testing Network+ webinar series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
URL:https://futurebloodtesting.org/event/democratising-healthcare-technology-the-role-and-challenges-of-participatory-design-in-healthcare/
LOCATION:Online
CATEGORIES:Online Event,Seminar
ATTACH;FMTTYPE=image/png:https://futurebloodtesting.org/wp-content/uploads/2024/09/FBTN-Webinar-Stephen.png
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20241015T120000
DTEND;TZID=Europe/London:20241015T130000
DTSTAMP:20260405T175549
CREATED:20240930T105934Z
LAST-MODIFIED:20241011T144659Z
UID:1894-1728993600-1728997200@futurebloodtesting.org
SUMMARY:Alzheimer’s disease Diagnosis and Plasma phospho-tau217-the ADAPT study
DESCRIPTION:Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-10-15 \n\nAbstract: Exciting progress is being made in the early and accurate detection of Alzheimer’s disease (AD) using blood tests. The most promising of these blood markers is plasma p-tau217. Dr Ashvini Keshavan will first review the evidence for concordance of plasma p-tau217 with gold standard Alzheimer’s disease biomarkers (i.e. amyloid positron emission tomography and cerebrospinal fluid tests) and the current state of commercial availability of plasma phosphorylated tau biomarkers including comparisons of effect sizes. She will then proceed with describing the plan for ADAPT\, a three-stage study including a UK multi-centre randomised controlled trial of disclosure of plasma p-tau217 results to patients and clinicians. From this study she aims to find out whether plasma p-tau217 helps to diagnose AD more quickly\, more accurately and at an earlier disease stage in comparison to routine memory clinic diagnostic pathways\, and we will obtain evidence for its cost effectiveness and acceptability to patients.\n\nBio: Dr Ashvini Keshavan is a senior clinical research fellow and honorary consultant neurologist at the Dementia Research Centre\, UCL Queen Square Institute of Neurology. A graduate of Trinity College\, Cambridge\, she completed postgraduate neurology training in London\, and obtained her PhD in 2019 on Cerebrospinal fluid and blood biomarkers of Alzheimer’s disease. Her ongoing work examines these biomarkers in clinical and pre-clinical cohorts\, aiming toward future application in more real-world settings\, serving diverse populations. She is the joint primary investigator for the UK-wide ADAPT (Alzheimer’s disease Diagnosis and Plasma p-Tau217) study.\n\nThis webinar is part of the 2024 Future Blood Testing Network+ webinar series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
URL:https://futurebloodtesting.org/event/alzheimers-disease-diagnosis-and-plasma-phospho-tau217-the-adapt-study/
LOCATION:Online
CATEGORIES:Online Event,Seminar
ATTACH;FMTTYPE=image/jpeg:https://futurebloodtesting.org/wp-content/uploads/2024/09/FBTN-Webinar-Ash-1.jpg
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241121
DTEND;VALUE=DATE:20241123
DTSTAMP:20260405T175549
CREATED:20241220T090649Z
LAST-MODIFIED:20241220T113713Z
UID:2064-1732147200-1732319999@futurebloodtesting.org
SUMMARY:Summary Report: Outcomes of the Future Blood Testing Network+ Digital Health Conference 2024
DESCRIPTION:The Future Blood Testing Network+ hosted a highly successful digital health conference on November 21–22\, 2024\, at Henley Business School Greenlands Campus. The two-day event brought together industry leaders\, academics\, healthcare professionals\, and policymakers to discuss innovations\, challenges\, and opportunities shaping the future of digital health and AI in healthcare. \nThe conference featured a rich program of engaging presentations\, panel discussions\, and interactive sessions. Key topics included advancements in diagnostic technologies\, the integration of AI into clinical workflows\, ethical considerations\, and policy implications. Participants explored collaborative strategies to bridge the gap between research and practical implementation in healthcare systems. \nWith its focus on collaboration and problem-solving\, the conference provided a unique platform for experts to address some of the most pressing challenges in digital health. Discussions highlighted how data and technology are driving healthcare improvements\, strategies to overcome barriers to interoperability and integration\, and priorities for scaling up innovative solutions. \nThis event reaffirmed its role as a premier forum for academics\, healthcare professionals\, innovators\, and partners to connect\, share ideas\, and work towards adopting digital tools that empower the health and care workforce while enhancing services for those who rely on them. \nKey Highlights: \nFeatured Sessions: Day 1 showcased a vibrant mix of keynote speakers and engaging interactive sessions. \n \n    \nThe topics addressed on day 1: \n\nDigital technology\, data and artificial intelligence in healthcare by Prof Weizi (Vicky) Li (University of Reading)\nData Science and AI to leverage Big BioMedical Data for the benefit of patients by Prof Jean-Baptiste Cazier (The Francis Crick Institute)\nDelivering the Thames Valley and Surrey NHS Secure Data Environment by Kerrie Woods (Oxford University Hospitals NHS Foundation Trust)\nA Radical Solution to the Visualisation and Interaction with Timeline Structured Information by Dr David Rew (University Hospital Southampton)\nDevelopment of a blood-based POC assay for real-time monitoring of inflammatory conditions such as sepsis and cancer by Dr David Sarphie (Seroxo Ltd)\nPre-hospital Virtual Care in BC\, Canada: What’s the case for remote blood testing and monitoring? by Prof Kendall Ho (University of British Columbia)\nThe power of standards in digital health by Emma Glass (British Standards Institution\, BSI)\nThe Future of Blood Testing for Digital Remote Care from Home for Precision Healthcare and Predictive Medicine by Dr Hector Zenil (King’s College London)\nData for developing diagnostics: measuring\, protecting\, analysing data by Dr Mark Preston (Prismea Limited)\nThe future of high quality immunoassay data- Certimmune by Dr Andrea Tattersall (Revvity)\nAgeing and Health: Genetic\, epigenetic\, and external influences by Dr Archana Sharma-Oates (University of Birmingham)\nBIOVIT: AI-Powered\, Bio-Based Personalised Nutrition Matched to an Individual’s Micronutrient Metabolism Type by Eimear Sutton and Ky Wright (BioVit)\nSmart Portable and Fast Acute Myocardial Infarction Detection Device for Ambulance Crew Use by Dr Xinli Du (Brunel University London)\nInnovation in rehabilitation technologies through multimodal blood analysis by Dr Jessie Howell and Nicole Hall (University of Strathclyde)\nOxonFair: A Flexible Toolkit for Algorithmic Fairness by Dr Zihao Fu (University of Oxford)\nSquishing Biology to Advance Healthcare: A Journey from Saliva to Blood by Dr Robert Barker (University of Kent)\n\nLaunch of the UK Laboratory Landscape Report: \nA cornerstone of the Network’s achievements and future opportunities\, the UK Laboratory Landscape Report\, The State of UK Diagnostics Post-COVID: Piecing Together the Landscape was presented by Prof Dimitris Grammatopolous (University of Warwick and UHCW NHS Trust). This comprehensive report provides a detailed analysis of the sector\, tackling critical challenges such as funding\, cost-saving opportunities through fit-for-purpose services\, staff shortages\, and the adoption of innovation. It also outlines key drivers for improvement and underscores the importance of enhanced collaboration among stakeholders to deliver high-quality\, accessible diagnostics for all. \nFeatured Sessions: Day 2 also showcased a vibrant mix of keynote speakers\, panel discussions\, and engaging interactive sessions. \n  \nThe topics addressed on day 2: \n\nExperience of developing a tool based on multimodal machine learning for the triage of referrals from general practice to a specialist rheumatology unit by Dr Anthony Bradlow (Royal Berkshire NHS Foundation Trust)\nRemote monitoring in Rheumatology by Dr Antoni Chan (Royal Berkshire NHS Foundation Trust)\nOnline health communities: The good\, the bad\, and the ugly by Prof Phillip Wu (Royal Holloway University of London)\nThe future regulation of IVDs in the UK by Stuart Angell (IVDeology Ltd)\nDigital Med Tech as an enabler for Precision Medicine by David Browning (Precision Health Technologies Accelerator)\nWearable and Implantable Optical Biosensors in Medical and Healthcare Applications by Dr Chenyang He (University of Nottingham)\nIntroducing Reading Health Data Institute by Dr William Flannery (Royal Berkshire NHS Foundation Trust)\n\nPanel Discussion on Healthcare’s Future Workforce: \nThe panel\, co-organized by the World of Work Institute (WOWI) and led by Prof Keiichi Nakata\, featured a diverse group of experts. Dr Melissa Carr and Lisa Barclay represented WOWI\, alongside Prof Kendall Ho offering an international perspective\, Prof Phillip Wu representing academia\, and Lucy Lehane from industry. \nThe panel explored how digital health is reshaping the future of work in healthcare\, focusing on improving the quality of life for healthcare workers. Discussions highlighted opportunities for workforce redistribution and diversification through new skills\, inclusive hiring practices\, and the creation of roles within the healthcare technology sector. \nThe audience actively engaged with the panelists\, discussion topics about equity\, diversity\, and inclusion. Panelists emphasized the critical need for retraining\, delved into ethical and governance challenges surrounding technology use\, and shared insights on strategies for managing organizational change through strong and effective leadership. \nNetworking Opportunities: \nThe event facilitated extensive networking opportunities\, with dedicated sessions for professionals to exchange ideas and forge new collaborations. Attendees praised the open and inclusive atmosphere\, which encouraged the sharing of knowledge across disciplines and sectors. \nReflections and Future Directions: \nClosing remarks from Network+ leaders emphasized the importance of sustained collaboration and innovation to meet the evolving needs of healthcare systems. Attendees were encouraged to build on the insights gained during the conference to drive impactful changes in their respective fields. The Network+ reaffirmed its commitment to fostering ongoing partnerships and dialogue through future events and research initiatives. \nThe conference reaffirmed the commitment to innovation\, inclusivity\, and multidisciplinary approaches in shaping the future of blood testing and digital health. \nWe extend our gratitude to all speakers and participants for their contributions to the success of this conference.
URL:https://futurebloodtesting.org/event/summary-report-outcomes-of-the-future-blood-testing-network-digital-health-conference-2024/
LOCATION:Greenlands\, Henley-On-Thames RG9 3AU\, Greenlands Campus\, Henley-On-Thames RG9 3AU\, Henley-on-Thames\, RG9 3AU\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://futurebloodtesting.org/wp-content/uploads/2024/12/B7A5696-Enhanced-NR.jpg
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20241121T100000
DTEND;TZID=Europe/London:20241122T153000
DTSTAMP:20260405T175549
CREATED:20240712T085826Z
LAST-MODIFIED:20241108T124346Z
UID:1738-1732183200-1732289400@futurebloodtesting.org
SUMMARY:Future blood testing network+: Digital Health conference 2024   
DESCRIPTION:Save the date and Register for the November conference here: https://futurebloodtesting.org/fbtn2024 \nView the Event Brochure \nJoin us at the Digital Health Conference on the 21st and 22nd November\, 2024\, at Henley Business School’s Greenlands Campus in Henley-on-Thames! This year’s FBTN Digital Health Conference is your opportunity to connect with leading experts and explore cutting-edge innovations in blood testing and digital health and AI. \nDescription: \nThe Future Blood Testing Network+ is dedicated to creating a multidisciplinary community focused on developing digital health technologies for remote\, rapid\, affordable\, and inclusive monitoring and personalized analytics. Our goal is to address three technology challenges\, namely remote monitoring\, information and communication technology\, personalised analytics and artificial intelligence (AI). \nOver the past two years we have hosted successful conferences\, including the Future Blood Testing: Challenges and Opportunities  2022 Conference and the Future of Healthcare: Remote Blood Testing\, Monitoring & AI 2023 Conference. This year\, we will address digital health technologies\, the role of AI in health\, and the associated challenges in the life\, work and the society. Our event will feature a distinguished line-up of industry leaders\, academics\, healthcare professionals\, and policymakers. \nWe will announce achievements and future opportunities in our Network+. We are also excited to announce that our latest landscape report\, “The UK Laboratory Landscape Report”\, will be launched at the event. This comprehensive report provides an in-depth analysis of the sector\, revealing funding\, the potential of cost savings over fit-for-purpose services\, staff shortages\, and adoption of innovation. It identifies key drivers for improvement and calls for stronger collaboration among stakeholders to ensure high-quality\, accessible diagnostics for all. \nWe are also thrilled to have the World of Work Institute (WOWI) co-host this year’s conference. WOWI is part of the Henley Business School and is dedicated to researching the evolving nature of work and its impact on organizations and individuals. The Institute’s current areas of focus are AI and automation\, equity\, diversity and inclusion\, and flexible working.  They will co-organize a panel discussion exploring how digital health is changing the future of work in healthcare. The attendance of WOWI session is free and open to all. \nDon’t miss this opportunity to connect with experts and explore the latest advancements and challenges in digital health at the FBTN Digital Health Conference. \nAgenda: \nDay 1: Thursday 21st November 2024  \n\n\n\n\n\n \nSession 1:  Session chair– Dr Samantha Pearman-Kanza (University of Southampton)\n\n\n10:00 \nGuest arrival\, Coffee & Registration \n\n\n10:20 \nWelcome and General Information \n\n\n10:25 \nDigital technology\, data and artificial intelligence in healthcare – Prof Weizi (Vicky) Li (University of Reading) \n\n\n10:40 \nData Science and AI to leverage Big BioMedical Data for the benefit of patients– Prof Jean-Baptiste Cazier (The Francis Crick Institute) \n\n\n11:05\nDelivering the Thames Valley and Surrey NHS Secure Data Environment – Kerrie Woods (Oxford University Hospitals NHS Foundation Trust) \n\n\n11:35\nA Radical Solution to the Visualisation and Interaction with Timeline Structured Information -Dr David Rew (University Hospital Southampton) \n\n\n12:00\nLunch and Networking \n\n\n \nSession 2: Session chair– Dr Bing Zhai (Northumbria University)\n\n\n13:00\nThe State of UK Diagnostics Post-COVID: Piecing Together the Landscape – Prof Dimitris Grammatopolous (University of Warwick and UHCW NHS Trust)\n\n\n13:30\nThe Future of Blood Testing for Digital Remote Care from Home for Precision Healthcare and Predictive Medicine – Dr Hector Zenil (King’s College London) \n\n\n13:55\nData for developing diagnostics: measuring\, protecting\, analysing data – Dr Mark Preston (Dr Prismea Limited) \n\n\n14:20\n The future of high quality immunoassay data- Certimmune – Dr Andrea Tattersall (Revvity)\n\n\n14:45\nDevelopment of a blood-based POC assay for real-time monitoring of inflammatory conditions such as sepsis and cancer – Dr David Sarphie (Seroxo Ltd)\n\n\n15:10\nCoffee Break & Networking \n\n\n \nSession 3: Session chair– Tim Dong ( Bristol Heart Institute) & Dr Bing Wang (University of Reading)\n\n\n15:40\nAgeing and Health: Genetic\, epigenetic\, and external influences– Dr Archana Sharma-Oates (University of Birmingham) \n\n\n16:00\nBIOVIT: AI-Powered\, Bio-Based Personalised Nutrition Matched to an Individual’s Micronutrient Metabolism Type – Eimear Sutton and Ky Wright (BioVit) \n\n\n16:20\nSmart Portable and Fast Acute Myocardial Infarction Detection Device for Ambulance Crew Use – Dr Xinli Du (Brunel University London) \n\n\n16:40\nInnovation in rehabilitation technologies through multimodal blood analysis – Dr Jessie Howell and Nicole Hall (University of Strathclyde)\n\n\n16:55\nOxonFair: A Flexible Toolkit for Algorithmic Fairness – Dr Zihao Fu (University of Oxford)\n\n\n17:10\nSquishing Biology to Advance Healthcare: A Journey from Saliva to Blood- Dr Robert Barker (University of Kent)\n\n\n17:30\nWrap Up & Networking Drinks \n\n\n19:00\nConference Dinner \n\n\n\n\n\nDay 2: Friday 22nd November 2024  \n\n\n\n\n\n \nSession 4: Session chair– Dr Pradip Moon & Basra Jehangir (University of Reading)\n\n\n09:00\nCoffee & Welcome Back  \n\n\n09:15\nPre-hospital Virtual Care in BC\, Canada: What’s the case for remote blood testing and monitoring? Prof Kendall Ho (University of British Columbia) \n\n\n09:40\nExperience of developing a tool based on multimodal machine learning for the triage of referrals from general practice to a specialist rheumatology unit – Dr Anthony Bradlow  (Royal Berkshire NHS Foundation Trust) \n\n\n10:00\nRemote monitoring in Rheumatology– Dr Antoni Chan (Royal Berkshire NHS Foundation Trust)\n\n\n10:20\nOnline health communities: The good\, the bad\, and the ugly – Professor Phillip Wu (Royal Holloway University of London) \n\n\n10:40\nDigital health and diagnostic tests: challenges when moving beyond test tubes and petri dishes – Dr Al Edwards (University of Southampton) \n\n\n11:00\nCoffee Break \n\n\n \nSession 5: Session chair– Dr Muhammad Salman Haleem (Queen Mary University of London)\n\n\n11:20\nThe future regulation of IVDs in the UK – Stuart Angell (IVDeology Ltd)\n\n\n11:45\nThe power of standards in digital health  – Emma Glass (British Standards Institution\, BSI)\n\n\n12:10\nDigital Med Tech as an enabler for Precision Medicine – David Browning (Precision Health Technologies Accelerator)\n\n\n12:35\nWearable and Implantable Optical Biosensors in Medical and Healthcare Applications – Dr Chenyang He (University of Nottingham) \n\n\n13:00\nLunch and Networking \n\n\n \nSession 6: Session chair- Prof Keiichi Nakata (University of Reading)\n\n\n14:00\nPanel Discussion: How will Digital Health change the future of work in healthcare? Prof Keiichi Nakata (University of Reading) Lisa Barclay (University of Reading) Dr Melissa Carr (University of Reading) Professor Phillip Wu (Royal Holloway University of London) Prof Kendall Ho (University of British Columbia) Lucy Lehane  (Lehane Consulting Ltd)\n\n\n15:30\nWrap up  \n\n\n\n\n\nFor more information about the event please email t.mudzinganyama@henley.ac.uk and s.pearman-kanza@reading.ac.uk.
URL:https://futurebloodtesting.org/event/future-blood-testing-network-digital-health-conference-2024/
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://futurebloodtesting.org/wp-content/uploads/2024/07/FBTN-NovWorkshop-Flyer.png
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
END:VCALENDAR